Recombinant SARS-CoV-2 NSP2 (C-6His)

Description

EnkiLife provides the Recombinant SARS-CoV-2 NSP2 (C-6His) protein,aslo know as SARS-CoV 2 nsp2,SARS-CoV 2 p65 homolog, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:Please contact with the lab for this information;Construction:Recombinant 2019-nCoV NSP2 is produced by our E.coli expression system and the target gene encoding Ala1-Gly638 is expressed with a 6His tag at the C-terminus.Accession:YP_009725298.1. Expression Host:E.coli.Species:SARS-CoV-2.Predicted Molecular Mass:73.6 KDa. Background:The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development.